Business Context and Reporting Period
Company: Tempus AI, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 30, 2025 (Event Date); July 3, 2025 (Completion Date)
Context: The filing details the completion of a private offering of convertible senior notes and a concurrent amendment to the company's existing credit agreement to facilitate the transaction and satisfy capital raise requirements.
Key Financial Metrics and Capital Structure
- Offering Size: $750.0 million aggregate principal amount of 0.75% Convertible Senior Notes due 2030 (includes full exercise of $100.0 million over-allotment).
- Net Proceeds: Approximately $721.7 million after discounts, commissions, and estimated expenses.
- Debt Repayment: $274.7 million of senior secured term loans repaid using offering proceeds.
- Transaction Costs: Approximately $41.8 million paid for capped call transactions.
- Interest Rate: 0.75% per annum on the Notes, payable semiannually starting January 15, 2026.
- Conversion Terms: Initial conversion price of approximately $84.19 per share (11.8778 shares per $1,000 principal), representing a 32.5% premium to the June 30, 2025 stock price.
- Capped Call Cap Price: $111.1950 per share (75% premium to June 30, 2025 stock price).
Material Changes Versus Prior Period
- Credit Agreement Amendment: Entered into a Fourth Amendment to the Credit Agreement on June 30, 2025. This amendment permitted the convertible note offering and satisfied a "junior capital raise requirement." Failure to meet this requirement would have triggered a 0.50% per annum increase in the applicable margin starting January 1, 2026.
- Capital Structure Optimization: Shifted from higher-cost senior secured term loans to lower-cost convertible debt (0.75% coupon), reducing immediate interest expense obligations.
- Liquidity Position: Significant increase in available liquidity through net proceeds of $721.7 million, partially offset by debt repayment and transaction costs.
Guidance, Outlook, and Risks
- Use of Proceeds: Remaining net proceeds will be used for general corporate purposes, including acquisitions, strategic investments, working capital, operating expenses, capital expenditures, and further debt repayment.
- Redemption Rights: The Company may not redeem the Notes prior to July 20, 2028. Redemption is permitted thereafter if the stock price exceeds 130% of the conversion price for a specified period.
- Conversion Conditions: Holders may convert prior to April 15, 2030, only under specific conditions (e.g., stock price trading above 130% of conversion price for 20 of 30 days, or significant trading price discounts).
- Risks and Contingencies:
- Dilution: Up to 11,803,575 shares of Common Stock may be issued upon conversion, subject to anti-dilution adjustments.
- Events of Default: Includes failure to pay interest/principal, failure to convert upon exercise, bankruptcy, and cross-defaults on indebtedness exceeding $75 million.
- Forward-Looking Statements: The filing includes standard disclaimers regarding market risks and uncertainties affecting the use of proceeds and future operations.
Investor Verification Checklist
- Verify the final net proceeds received and the exact amount of term loans repaid to confirm the net cash impact on the balance sheet.
- Review the full text of the Fourth Amendment to the Credit Agreement (Exhibit 10.2) to confirm no other restrictive covenants were added.
- Monitor the stock price relative to the conversion price ($84.19) and the capped call cap price ($111.1950) to assess potential dilution scenarios.
- Confirm the status of the "junior capital raise requirement" to ensure the 0.50% margin increase on the credit facility is definitively avoided.
- Check subsequent filings for any changes in the use of proceeds, particularly regarding planned acquisitions or strategic investments.